MultiplexDX is Diagnostic Equipment in United States that focus on histopathological methods business. Founded in 2015. They cover business area such as developer, molecular diagnostic service, cancer misdiagnosis, accurate, quantitative, and accessible diagnostic test, molecular biology, histopathological method, tumor, oncology patient, their normal life, proper diagnosis.
2015
( 9 years old in 2024 )
Histopathological Methods
-
One Research Court
Suite 450
Rockville, MD 20850
United States
Private
developermolecular diagnostic servicecancer misdiagnosisaccurate, quantitative, and accessible diagnostic testmolecular biologyhistopathological methodtumoroncology patienttheir normal lifeproper diagnosis
* We use standard office opening hours in near MultiplexDX's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MultiplexDX is Diagnostic Equipment business from United States that founded in 2015 (9 years old in 2024), MultiplexDX business is focusing on Histopathological Methods.
MultiplexDX headquarter office and corporate office address is located in One Research Court Suite 450 Rockville, MD 20850 United States.
MultiplexDX was founded in United States.
In 2024, MultiplexDX is currently focus on histopathological methods sector.
Above is snippet of Google Trends for "histopathological methods" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MultiplexDX, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.